The lau ch ep ese ts a othe milesto e i MediGuide’s i ovatio oadmap a d eflects AIAI Holdi gs’ st ategy of suppo ti g po tfolio compa ies that espo sibly i teg ate adva ced tech ologies i to scalable, eal-wo ld busi ess applicatio s.
“Eve y patie t is diffe e t, yet too ma y healthca e decisio s a e still guided by ge e alized t eatme t app oaches. We believe people dese ve ca e that’s i fo med by thei u ique biology, medical histo y, a d i dividual health eeds,” said Ve a Gue ei o, Chief Executive Office of MediGuide. “Ou p ecisio healthca e solutio b i gs togethe adva ced medical i tellige ce, expe t cli ical eview, a d AI-e abled i sights to help make that level of pe so alized ca e mo e accessible.”
“O e of AIAI Holdi gs’ co e objectives is to pa t e with exceptio al ma ageme t teams that a e buildi g i ovative, tech ology-e abled busi esses capable of c eati g lo g-te m sha eholde value,” comme ted Todd Fu iss, Chief Executive Office a d Co-Fou de of AIAI Holdi gs.
“MediGuide’s latest state of the a t healthca e offe i g is a excelle t example of that st ategy i actio . By combi i g a tificial i tellige ce with wo ld-class cli ical expe tise, MediGuide co ti ues to st e gthe its positio i o e of healthca e’s fastest-g owi g ma kets while adva ci g solutio s desig ed to imp ove patie t outcomes.”
The ew offe i g builds upo MediGuide’s established Medical Seco d Opi io (MSO) se vices by combi i g ge etic, molecula , cli ical, a d lifestyle i fo matio with AI-e abled a alytics a d expe t physicia eview. This i teg ated app oach helps imp ove diag ostic co fide ce, suppo ts ea lie detectio , a d e ables mo e pe so alized t eatme t ecomme datio s tailo ed to each patie t’s u ique cli ical p ofile.
Key capabilities of the ew offe i g will i clude:
The lau ch comes as i su e s a d ei su e s face isi g claims tied to specialist efe als, i c easi g dema d fo i te atio al pa t e s that ca p ovide cli ical eview a d evide ce-based ecomme datio s athe tha epo ts alo e.Lea mo e at MediGuide: www.mediguide.com.
AIAI Holdi gs Co po atio (Ai2) (NASDAQ:AIAI) is a AI-e abled dive sified holdi g compa y that acqui es a d g ows compa ies ac oss multiple i dust ies. We expect to d ive eve ue a d ea i gs g owth th oughout ou po tfolio by applyi g exclusively lice sed T a sfo matio al AI to e ha ce ope atio al efficie cy a d fi a cial pe fo ma ce.
Ai2 is buildi g a ext-ge e atio model fo tech ology-e abled busi ess ope atio s, which is expected to c eate sustai able value fo sha eholde s th ough the st ategic i teg atio of a tificial i tellige ce ac oss dive se i dust ies.
MediGuide is a global medical i tellige ce compa y dedicated to helpi g i dividuals make i fo med healthca e decisio s whe they matte most. Fou ded i 1999, the Compa y p ovides Medical Seco d Opi io s, Medical T eatme t Ab oad, Digital Health, a d P eve tive Health solutio s th ough a i teg ated healthca e platfo m that co ects membe s with wo ld- e ow ed medical ce te s a d leadi g specialists a ou d the globe.
Ope ati g ac oss mo e tha 160 cou t ies with a etwo k spa i g five co ti e ts, MediGuide pa t e s with i su e s, employe s, fi a cial i stitutio s, a d healthca e o ga izatio s to delive expe t cli ical guida ce, pe so alized ca e avigatio , a d i ovative digital health se vices. By combi i g wo ld-class medical expe tise with adva ced tech ology a d AI-e abled healthca e solutio s, MediGuide empowe s patie ts with g eate co fide ce, imp oved cli ical outcomes, a d access to the highest sta da ds of ca e wo ldwide. Lea mo e at MediGuide.
MediGuide is a po tfolio compa y of AIAI Holdi gs Co po atio (NASDAQ:AIAI).
This p ess elease co tai s “fo wa d-looki g stateme ts” o “fo wa d-looki g i fo matio ” withi the mea i g of the P ivate Secu ities Litigatio Refo m Act of 1995, i cludi g stateme ts ega di g the pla s, i te tio s, beliefs, a d cu e t expectatio s of the Compa y with espect to futu e busi ess activities a d pla s of the Compa y. All stateme ts co tai ed i this p ess elease that do ot elate to matte s of histo ical fact should be co side ed fo wa d-looki g stateme ts, i cludi g without limitatio stateme ts ega di g ou expectatio s, i te tio s, beliefs, pla s, objectives, goals, st ategies, futu e eve ts o pe fo ma ce, a d u de lyi g assumptio s. Fo wa d-looki g stateme ts a e ofte ide tified by the use of wo ds such as “may,” “will,” “expect,” “believe,” “a ticipate,” “i te d,” “would,” “could,” “should”, “estimate,” “pla ,” “p edict,” “p oject,” “estimate”, o “co ti ue,” o simila exp essio s, i cludi g the egative of these te ms o othe compa able te mi ology.
Fo wa d-looki g stateme ts a e based o the Compa y’s cu e t expectatio s ega di g its st ategy, pla s, i te tio s, pe fo ma ce, o futu e occu e ces o esults, the i fo matio o which such expectatio s we e based may cha ge. These fo wa d-looki g stateme ts ely o a umbe of assumptio s co ce i g futu e eve ts a d a e subject to a umbe of k ow a d u k ow isks, u ce tai ties, a d othe facto s, ma y of which a e outside of the Compa y’s co t ol, that could cause actual esults, pe fo ma ce, o achieveme ts to mate ially diffe f om a y futu e esults, pe fo ma ce, o achieveme ts exp essed o implied by the fo wa d-looki g stateme ts. Such isks, u ce tai ties a d othe facto s i clude, but a e ot limited to ou lack of ope ati g histo y, ou ability to att act ew i vestme ts, ou failu e to ma age g owth effectively, ou acquisitio activities may pose isks that could ha m ou busi ess, a d ou lice sed AI may ot pe fo m up to the expected sta da ds, as well as ge e al busi ess a d eco omic co ditio s, competitive p essu es, egulato y cha ges, tech ological developme ts, a d othe facto s ide tified i the Compa y’s most ece t fili gs with the U.S. Secu ities a d Excha ge Commissio , i cludi g ou Regist atio Stateme t o Fo m S-1, which a e available fo eview at www.sec.gov. Fu the mo e, the Compa y ope ates i a competitive e vi o me t whe e ew a d u a ticipated isks may a ise. Acco di gly, i vesto s should ot place a y elia ce o fo wa d-looki g stateme ts as a p edictio of actual esults.
The fo wa d-looki g stateme ts i this p ess elease a e based o i fo matio available to us as of the date he eof, a d we disclaim a y i te tio to, a d, except as may be equi ed by law, u de take o obligatio to, update o evise fo wa d-looki g stateme ts to eflect eve ts o ci cumsta ces that subseque tly occu o of which the Compa y he eafte become awa e. These fo wa d-looki g stateme ts should ot be elied upo as ep ese ti g ou views as of a y date subseque t to the date of this p ess elease.
Matthew Seli ge , Se io Pa t e I teg ous Commu icatio sEmail:
Website: www.aiaiholdi gs.comLi kedI : https://www.li kedi .com/compa y/aiaiholdi gs/X/Twitte : https://x.com/_AiSqua edI stag am: https://www.i stag am.com/_aisqua ed/Facebook: https://www.facebook.com/aiaiholdi gs
